Supplemental material
Journal of Market Access & Health Policy
Volume 9, 2021 - Issue 1
Open access
2,774
Views
7
CrossRef citations to date
0
Altmetric
Original Research Article
Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
Anuraag R. Kansala Evidera, Inc., Waltham, MA, USA
, Odette S. Reifsnidera Evidera, Inc., Waltham, MA, USA
, Sarah B. Branda Evidera, Inc., Waltham, MA, USA
, Neil Hawkinsb Visible Analytics, Oxford, UK
, Anna Coughlana Evidera, Inc., Waltham, MA, USA
, Shujun Lia Evidera, Inc., Waltham, MA, USA
, Lael Cragina Evidera, Inc., Waltham, MA, USA
, Clark Paramorec Bluebird Bio, Cambridge, MA, USA
, Andrew C. Dietzc Bluebird Bio, Cambridge, MA, USA
& J. Jaime Caroa Evidera, Inc., Waltham, MA, USACorrespondence[email protected]
https://orcid.org/0000-0001-5470-3754
Article: 1922028
|
Received 10 Dec 2020, Accepted 21 Apr 2021, Published online: 07 Jun 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.